The largest database of trusted experimental protocols

Rhlaminin 521

Manufactured by Thermo Fisher Scientific
Sourced in United States

RhLaminin-521 is a recombinant human laminin-521 protein. Laminin-521 is a major component of the extracellular matrix and plays a crucial role in cell adhesion, migration, and differentiation. RhLaminin-521 can be used as a cell culture substrate to support the growth and maintenance of various cell types.

Automatically generated - may contain errors

8 protocols using rhlaminin 521

1

Isolation and Culture of Mouse Satellite Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quiescent satellite cells were collected from the skeletal muscles of 8-week-old male SJS-model mice using fluorescence-activated cell sorting and an SM/C-2.6 antibody, as described previously [31 (link)]. The SM/C-2.6 antibody was provided by Dr. Fukada. These satellite cells were seeded on rhLaminin-521 (Thermo Fisher Scientific)-coated plates and cultured in satellite cell growth media (Dulbecco’s modified Eagle’s medium (DMEM), 20% fetal bovine serum, 10% horse serum, chicken embryo extract (United States Biological, Salem, MA, USA), and penicillin/streptomycin) containing 2.5 µg/mL recombinant human FGF (ProteinTech, Rosemont, IL, USA), as previously described [32 (link),33 (link)]. Satellite cells were differentiated to myotubes by culturing in high glucose DMEM (Thermo Fisher Scientific), supplemented with 2% horse serum (Thermo Fisher Scientific) and penicillin/streptomycin. To rescue perlecan-null myotubes, recombinant perlecan protein (20 μg/mL; purified and provided by Dr. Sasaki) was added at the start of the differentiation process. Calcium imaging experiments were performed 12–16 h after adding 70 µg/mL laminin/entactin complex (Corning Inc., Corning, NY, USA) and 10 ng/mL recombinant neural agrin (R&D Systems, Minneapolis, MN, USA).
+ Open protocol
+ Expand
2

Episomal Reprogramming for iPSC Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expanded erythroid cells were reprogrammed with Episomal iPSC Reprogramming Kit (Thermofisher Catalog#A15960). Around 3 × 105 cells were electroporated with 1 μg of each episomal vector using Neon Transfection System (Thermofisher). The emerging ESC-like colonies were manually picked and transferred into 96-well plates coated with rhLaminin-521 (Thermofisher Catalog#A29248) in the cGMP-grade mTeSR™ Plus medium (StemCell Technologies Catalog #100-0276). iPSCs were dissociated using the enzyme-free cGMP-grade ReLeSR (StemCell Technologies Catalog # 100-0484) using 1:10–1:30 splitting ratio and incubated at 37 °C, 5% CO2, 20% O2 incubator.
+ Open protocol
+ Expand
3

Episomal plasmid reprogramming of hDFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 8 μg of episomal plasmid (pCXLE-hSK, pCXLE-hUL, pCXLE-hOCT3/4-shp53-F, and pCXWB-EBNA1) and 8 μg of dbDNA reprograming vectors (dbDNA-hSK, dbDNA-hUL, dbDNA-OCT4) were prepared. The net weight equivalents of the vectors resulted in a ratio of 1.49:1 (dbDNA:oriP-EBNA1) in terms of vector copies. The vectors were resuspended in Nucleofector solution (Lonza) along with 4.5 × 105 hDFs. The solution was then nucleofected with the Amaxa Nucleofector 2b system (Lonza) before being re-seeded in complete DMEM (DMEM supplemented with 10% FBS, 1% Pen/Strep [penicillin-streptomycin], 1% non-essential amino acids [NEAAs], 4% 200 mM l-glutamine; all Sigma-Aldrich). On day 7 post-nucleofection, the reprograming cells were re-seeded onto an inactive murine embryonic fibroblast (iMEF) feeder layer (Cambridge Bioscience) in complete DMEM. Twenty-four hours after re-plating, the medium was altered to hESC medium supplemented with FGF2 (10 ng/mL) (R&D Systems) until primary colony formation.
Feeder-free reprogramming was performed where the reprograming procedure was carried out as normal but the hESC medium was replaced with Essential 8 (Gibco) and the iMEF feeder layer for rhLaminin521 (Thermo Fisher Scientific).
+ Open protocol
+ Expand
4

Generation and Characterization of hPSC Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The H1 hESC line was purchased from WiCell Institute. The H1-iCas9 ESC line is a gift from Danwei Huangfu’s laboratory. The wild-type iPSC line was reprogrammed and well characterized in previous studies [44 (link), 56 (link), 57 (link)]. The study was approved by the KAUST Institutional Biosafety and Bioethics Committee (IBEC). All hPSCs were cultured in Essential 8 medium (ThermoFisher, Cat# A1517001) in rhLaminin-521 (ThermoFisher, Cat# A29249) coated wells with medium change daily. The peripheral blood mononuclear cells were isolated from the whole blood of a healthy donor via a standard Ficoll-Paque-based protocol and further cultured in StemSpan™-ACF Erythroid Expansion medium (STEMCELL Technology, Cat# 09860) for 13 days with medium change every 3 days to expand the erythroid progenitors. The erythroid progenitors were analyzed by FACS before CRISPR-Cas9 editing.
+ Open protocol
+ Expand
5

CRISPR-Cas9 Knockout of WAS Gene in iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used a previously well-characterized wild-type iPSC line26 ,33 (46XX) to perform homozygous knockout of the WAS gene using CRISPR-Cas9. To knock out the entire WAS gene, sgRNAs targeting upstream and downstream of the WAS gene with the following protospacer and protospacer-adjacent motif (PAM) sequences–5’-CCAAGCTCAGCCTAACGAGG-AGG-3’ (upstream) and 5’-GGATTTCACCCCCTAAGGGC-AGG-3’ (downstream)–were synthesized by in vitro transcription using the T7 MEGAshortscript kit (Thermo Fisher Scientific). Neon transfection system (Thermo Fisher Scientific; 1600 v/10 ms/3 pulses) was used for electroporating 200 k single cells with 50 pmol Cas9 protein and 25 pmol each sgRNA ribonucleoprotein complexes (RNPs) in buffer R (provided by Neon kit). After electroporation, iPSCs were cultured in Essential 8 medium (Thermo Fisher Scientific) with ROCKi (Abcam) on rhLaminin521 (Thermo Fisher Scientific) coated 24-well plates. The cells were dissociated by TrypleE after 48 h and subsequently 1000 single cells were seeded on laminin521 coated six-well plates. After 7 days half of the colony was picked for genotyping by PCR using the following primers: (F1, 5’-GTAGTAACCCTTCCGGACTA-3’ and R1, 5’-CGTAAAGGCGGATGAAGTAG-3’; F2, 5’-TCACACTCACCCAACAATCC-3’ and R2, 5’-TAACTGGGCCGACATTTCTC-3’, see Fig. 1d). The genotyping results were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
6

Transwell Assay for Th17 Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transwell filters (5 μm, Costar) were coated with rhlaminin-511 (BioLamina), rhlaminin-521 (Thermo Fisher Scientific), or BSA in HBSS containing calcium and magnesium (HBSS+CaMg) (0.2 μg/cm2) at 37°C for 2 h, and washed with HBSS+CaMg. 72-h-in vitro-polarized mouse pTh17, Th17, or 6-d-in vitro-polarized human Th17 cells in RPMI 1640 media supplemented with HEPES (10 mM), sodium pyruvate (1 mM), penicillin (10 U/ml), streptomycin (10 μg/ml), gentamicin (50 μg/ml), and β-mercaptoethanol (55 μM) (incomplete RPMI) were added to the Transwell filters. Transmigration was induced with complete RPMI in the bottom chamber. To limit the contribution of CCR6, we used FBS as a general chemoattractant instead of CCL20. After 6 h at 37°C, the transmigrated cells were counted and expressed as a percentage of total cells added to the upper chamber. To neutralize human integrin α3, human Th17 cells were incubated in the presence of anti-integrin α3 antibody (Sigma-Aldrich, P1B5, 20 ng/ml) for 15 min at 37°C before addition to the Transwell filters.
+ Open protocol
+ Expand
7

Progenitor-Enriched Muscle Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Progenitor‐enriched cell populations were isolated from muscle samples as described previously (Vaughan & Lamia, 2019 ), and cultured on Matrigel (BD Biosciences, Franklin Lake, NJ, USA) at 39°C in Dulbecco's modified Eagle's medium (DMEM) high glucose with 1% P/S, supplemented with 20% fetal bovine serum (FBS) (Life Technologies, Carlsbad, CA, USA) and 5 ng mL–1 basic FGF (PeproTech, London, UK). Cells were trypsinized and passaged every 2−3 days. MPCs were differentiated using a protocol adapted from Hausman & Poulos (2005 (link)). In short, MPCs were plated on rh‐Laminin 521 (Life Technologies)‐coated wells (1000 cells mm–2) and, when they reached 70% confluency, media was changed to DMEM high glucose with antibiotics supplemented with 10% FBS and 80 nm dexamethasone (Sigma‐Aldrich). Forty‐eight hours later or when cells reached full confluence (day 0), media was changed to DMEM high glucose with antibiotics supplemented with 2% FBS, 1% of insulin‐transferrin‐selenium (Life Technologies) and, in some experiments, human FGF21 (1−100 ng mL–1; #100‐42; PeproTech), and maintained for up to 7 days. All experiments with cells were performed using triplicate wells.
+ Open protocol
+ Expand
8

Myogenic Differentiation of MDPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were differentiated as per a previously published protocol63 (link) with minor changes. In short, MDPCs (5 × 104) were seeded in triplicate on rh-Laminin 521 (0.5 µg/cm2, Life Technologies)-coated 24-well or 96-well plates plates with growth media (DMEM supplemented with 10% FBS, 5 ng/ml bFGF and 1% PS). Once cells reached 70% confluency, media was changed to muscle proliferation media containing 80 nM dexamethasone (Sigma Aldrich), 10% FBS and 1% PS, until they reached full confluence, at which point (Day 0) media was replaced with serum free medium supplemented with 1% Insulin-Transferrin-Selenium (100×, Life Technologies) and 1% PS. Samples were taken on Days 0, 3 and 5 in TRIzol reagent and stored at – 80 °C, or cells on Day 5 were fixed in 4% PFA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!